Insider · CIK 0001546216

Goff Brian

CIK 0001546216 Name as filed on the most recent filing

Filed as Goff Brian (15)

21 transaction lines · from 15 filings · filed 2018-02-08 to 2026-04-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

21 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-04-02 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 2 lines 661,850, disposed Open Form 4 filing 0001439222-26-000057
2026-03-02 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 3 lines 522,873, disposed Open Form 4 filing 0001439222-26-000044
2025-12-30 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 2 lines 506,664, disposed Open Form 4 filing 0001439222-26-000008
2025-08-08 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 406,487, disposed Open Form 4 filing 0001439222-25-000093
2025-06-24 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 2 lines 627,198, disposed Open Form 4 filing 0001439222-25-000063
2025-03-03 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 2 lines 460,136, disposed Open Form 4 filing 0001439222-25-000015
2024-08-08 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 474,140, disposed Open Form 4 filing 0001439222-24-000123
2024-06-05 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 591,697, disposed Open Form 4 filing 0001439222-24-000073
2024-03-05 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 135,361, disposed Open Form 4 filing 0001439222-24-000048
2024-01-24 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 165,221, disposed Open Form 4 filing 0001439222-24-000014
2024-01-09 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 277,397, disposed Open Form 4 filing 0001439222-24-000010
2023-08-08 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 259,335, disposed Open Form 4 filing 0001439222-23-000123
2023-06-30 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 324,694, disposed Open Form 4 filing 0001439222-23-000103
2018-06-08 S, Open-market sale Alexion Pharmaceuticals IncALXN 194,982, disposed Open Form 4 filing 0000899866-18-000102
2018-02-08 S, Open-market sale Alexion Pharmaceuticals IncALXN 192,028, disposed Open Form 4 filing 0000899866-18-000042

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 21
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Goff Brian, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001546216

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.